1/48
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Components of emotion process
Cognition (interpretation), Action (behavioral/physiological), Feeling (subjective experience)
Facial feedback hypothesis
Emotions are partially generated by perception of bodily responses and actions
Behavioral Activation System (BAS)
Motivated by rewards; energizes action
Behavioral Inhibition System (BIS)
Sensitive to punishment; inhibits behavior
Broaden‑and‑Build Theory
Positive emotions broaden attention and build lasting personal resources
ANS activation in emotion
Emotional states activate the autonomic nervous system
Emotion‑specific ANS arousal
Different emotions correspond to different mixes of sympathetic & parasympathetic activity
vmPFC damage effects
Impaired decision‑making, blunted guilt, excessive indecision
PFC lesion effect
Impaired anticipation of emotional consequences
Limbic system key node
Amygdala
PFC role in emotion
Regulates and controls emotional responses
Left hemisphere emotion
Approach behaviors (BAS): happiness or anger
Right hemisphere emotion
Avoidance/withdrawal behaviors (BIS): fear, disgust, guilt
Selye's stress definition
Non‑specific bodily response to any demand (General Adaptation Syndrome)
McEwen's stress definition
An interpreted threat that triggers physiological & behavioral responses
General Adaptation Syndrome (GAS)
Phase 1 alarm (SNS), Phase 2 adaptation (HPA); nonspecific stress response
SNS in stress
Fast branch; releases epinephrine & norepinephrine; dilates pupils, increases heart rate
HPA axis in stress
Slower branch; CRH→ACTH→cortisol release from adrenal cortex
Hypothalamus in HPA negative feedback
Inhibits further CRH and ACTH release to return system to baseline
Stress‑signal origins
Amygdala, locus coeruleus, dorsal raphe nucleus activate medulla (SNS) & PVN (HPA)
Acetylcholine in ANS
Neurotransmitter for preganglionic autonomic fibers
Norepinephrine in ANS
Neurotransmitter for postganglionic sympathetic fibers
Vagus nerve function
Reports peripheral arousal state back to the brain
Cortisol functions
Mobilizes energy, suppresses nonessential functions; chronic high cortisol lowers BDNF
DHEA function
Buffers cortisol effects; supports immune & cognitive performance
Oxytocin in stress
Promotes "tend‑and‑befriend": reduces SNS reactivity & builds social bonds
Psychoneuroimmunology
Study of how psychological factors (e.g., stress) affect immune responses
Cytokines & sickness behavior
Psychological stress raises cytokines, triggering fatigue, fever, low energy
Tend‑and‑befriend response
Oxytocin‑mediated affiliative stress response, especially in females
MDD diagnostic criteria
≥5 symptoms over 2 weeks including depressed mood or loss of pleasure
Depression structural changes
↓ volume in hippocampus, OFC, ACC
Depression functional changes
Amygdala hyperactivity; dmPFC hypoactivity; weakened amygdala-vmPFC/dmPFC connectivity
Reward dysfunction in MDD
Nucleus accumbens less responsive to reward
Evolutionary role of negative emotions
Signal need to change environment/behavior; conserve energy; withdraw from conflict
Evolutionary definition of disorder
Failure to activate when needed, activate inappropriately, or coordinate with other systems
MAOI mechanism
Block monoamine oxidase to prevent breakdown of monoamines
Tricyclic antidepressants
Block reuptake of 5‑HT, NE, and DA; many side effects
SSRI mechanism
Block serotonin reuptake; fewer side effects than tricyclics
Atypical antidepressants
Varying mechanisms (DA or glutamate); examples: Wellbutrin, ketamine
Neuroplasticity hypothesis of recovery
Antidepressants ↑ BDNF → increased neurogenesis, synaptic growth, learning capacity
BDNF role
Supports neuronal health, growth, and connectivity; low BDNF → reduced plasticity
BDNF‑related treatments
SSRIs, ECT, rTMS, exercise, ketamine, psychedelics all ↑ BDNF or neuroplasticity
Anxiolytic drug class
GABA‑A receptor agonists increase inhibitory signaling in the brain
Benzodiazepine mechanism
Bind GABA‑A receptors to enhance GABA's calming effects
Common benzodiazepines
Xanax (alprazolam), Ativan (lorazepam), Klonopin (clonazepam), Valium (diazepam)
Neurotransmitter imbalance theory issues
Serotonin levels not reliably low; depleting 5‑HT doesn't induce depression; SSRIs act slowly
Psychedelics & DMN
Psilocybin ↓ activity in mPFC, ACC, PCC (Default Mode Network) to reduce rumination
Psilocybin vs SSRI trials
Psilocybin showed greater improvement than escitalopram, independent of treatment expectancy
Trait suggestibility effect
Psilocybin outcomes correlated with suggestibility, indicating increased psychological flexibility